L. Roy Papp & Associates LLP Has $11.67 Million Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

L. Roy Papp & Associates LLP trimmed its holdings in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 3.0% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,883 shares of the medical instruments supplier's stock after selling 310 shares during the quarter. Mettler-Toledo International accounts for about 1.4% of L. Roy Papp & Associates LLP's portfolio, making the stock its 21st biggest holding. L. Roy Papp & Associates LLP's holdings in Mettler-Toledo International were worth $11,671,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of MTD. Farther Finance Advisors LLC raised its position in shares of Mettler-Toledo International by 14.3% in the fourth quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier's stock valued at $78,000 after purchasing an additional 8 shares during the period. Apollon Wealth Management LLC increased its holdings in Mettler-Toledo International by 2.5% in the 4th quarter. Apollon Wealth Management LLC now owns 368 shares of the medical instruments supplier's stock valued at $451,000 after buying an additional 9 shares during the period. Steward Partners Investment Advisory LLC increased its holdings in Mettler-Toledo International by 3.0% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 306 shares of the medical instruments supplier's stock valued at $374,000 after buying an additional 9 shares during the period. Atlantic Union Bankshares Corp increased its holdings in Mettler-Toledo International by 0.5% in the 4th quarter. Atlantic Union Bankshares Corp now owns 2,083 shares of the medical instruments supplier's stock valued at $2,549,000 after buying an additional 10 shares during the period. Finally, 1900 Wealth Management LLC boosted its stake in shares of Mettler-Toledo International by 4.9% in the 4th quarter. 1900 Wealth Management LLC now owns 257 shares of the medical instruments supplier's stock valued at $314,000 after purchasing an additional 12 shares in the last quarter. 95.07% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

MTD has been the topic of several recent analyst reports. Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price on the stock in a research note on Monday, April 7th. UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and cut their target price for the company from $1,530.00 to $1,350.00 in a research report on Tuesday, May 20th. Wells Fargo & Company upped their price target on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an "equal weight" rating in a research note on Monday, May 5th. Robert W. Baird lowered their price target on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating for the company in a research note on Tuesday, April 22nd. Finally, Evercore ISI increased their target price on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an "outperform" rating in a research note on Monday, February 10th. Seven equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $1,302.11.

Mettler-Toledo International Price Performance

NYSE:MTD traded up $19.27 during trading hours on Friday, reaching $1,183.88. 158,407 shares of the stock were exchanged, compared to its average volume of 151,391. Mettler-Toledo International Inc. has a twelve month low of $946.69 and a twelve month high of $1,546.93. The firm has a 50 day moving average of $1,092.37 and a 200 day moving average of $1,205.15. The stock has a market cap of $24.60 billion, a PE ratio of 29.21, a PEG ratio of 3.30 and a beta of 1.38.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share for the quarter, topping analysts' consensus estimates of $7.90 by $0.29. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. The firm had revenue of $883.74 million during the quarter, compared to the consensus estimate of $876.61 million. During the same quarter in the prior year, the firm posted $8.89 EPS. The business's revenue was down 4.6% on a year-over-year basis. Equities research analysts anticipate that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current year.

Insider Activity

In other news, Director Michael A. Kelly sold 1,062 shares of the stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the completion of the sale, the director now owns 120 shares of the company's stock, valued at approximately $139,191.60. This represents a 89.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.94% of the stock is currently owned by insiders.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.